Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad-Ali Jenabian

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
AIDS (London, England)|April 6, 2016
The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infectionVikram Mehraj, Mohammad-Ali Jenabian, Rosalie Ponte, et al.
Retrovirology|May 1, 2015
Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ARTSandrina DaFonseca, Julia Niessl, Sylvia Pouvreau, et al.
JCI Insight|July 24, 2023
Early ART reduces viral seeding and innate immunity in liver and lungs of SIV-infected macaquesJulien A Clain, Henintsoa Rabezanahary, Gina Racine, et al.
AIDS (London, England)|February 15, 2021
Antiretroviral therapy-treated HIV-infected adults with coronary artery disease are characterized by a distinctive regulatory T-cell signatureCéline Rothan, Alexis Yero, Tao Shi, et al.
AIDS (London, England)|September 28, 2016
Immune tolerance properties of the testicular tissue as a viral sanctuary site in ART-treated HIV-infected adultsMohammad-Ali Jenabian, Cecilia T Costiniuk, Vikram Mehraj, et al.
HIV Research & Clinical Practice|January 6, 2021
Impact of extended-release niacin on immune activation in HIV-infected immunological non-responders on effective antiretroviral therapyBertrand Lebouché, Alexis Yero, Tao Shi, et al.
AIDS Research and Treatment|January 5, 2017
Analytical Performances of Human Immunodeficiency Virus Type 1 RNA-Based Amplix® Real-Time PCR Platform for HIV-1 RNA QuantificationChristian Diamant Mossoro-Kpinde, Ralph-Sydney Mboumba Bouassa, Mohammad-Ali Jenabian, et al.
Cannabis and Cannabinoid Research|August 29, 2025
Impact of Oral Cannabinoids on the Endocannabinoidome and Gut Microbiome in People with HIV on Antiretroviral Therapy (CTN PT028 Pilot Clinical Trial)Giada Giorgini, Cristoforo Silvestri, Ralph-Sydney Mboumba Bouassa, et al.
Plos Pathogens|May 10, 2013
Regulatory T cells negatively affect IL-2 production of effector T cells through CD39/adenosine pathway in HIV infectionMohammad-Ali Jenabian, Nabila Seddiki, Ahmad Yatim, et al.
AIDS and Behavior|November 7, 2022
Disentangling Medicinal and Recreational cannabis Use Among People Living with HIV: An Ecological Momentary Assessment StudyJeffrey D Wardell, Sergio Rueda, Nicolle Fox, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
AIDS (London, England)|April 6, 2016
The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infectionVikram Mehraj, Mohammad-Ali Jenabian, Rosalie Ponte, et al.
Retrovirology|May 1, 2015
Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ARTSandrina DaFonseca, Julia Niessl, Sylvia Pouvreau, et al.
JCI Insight|July 24, 2023
Early ART reduces viral seeding and innate immunity in liver and lungs of SIV-infected macaquesJulien A Clain, Henintsoa Rabezanahary, Gina Racine, et al.
AIDS (London, England)|February 15, 2021
Antiretroviral therapy-treated HIV-infected adults with coronary artery disease are characterized by a distinctive regulatory T-cell signatureCéline Rothan, Alexis Yero, Tao Shi, et al.
AIDS (London, England)|September 28, 2016
Immune tolerance properties of the testicular tissue as a viral sanctuary site in ART-treated HIV-infected adultsMohammad-Ali Jenabian, Cecilia T Costiniuk, Vikram Mehraj, et al.
HIV Research & Clinical Practice|January 6, 2021
Impact of extended-release niacin on immune activation in HIV-infected immunological non-responders on effective antiretroviral therapyBertrand Lebouché, Alexis Yero, Tao Shi, et al.
AIDS Research and Treatment|January 5, 2017
Analytical Performances of Human Immunodeficiency Virus Type 1 RNA-Based Amplix® Real-Time PCR Platform for HIV-1 RNA QuantificationChristian Diamant Mossoro-Kpinde, Ralph-Sydney Mboumba Bouassa, Mohammad-Ali Jenabian, et al.
Cannabis and Cannabinoid Research|August 29, 2025
Impact of Oral Cannabinoids on the Endocannabinoidome and Gut Microbiome in People with HIV on Antiretroviral Therapy (CTN PT028 Pilot Clinical Trial)Giada Giorgini, Cristoforo Silvestri, Ralph-Sydney Mboumba Bouassa, et al.
Plos Pathogens|May 10, 2013
Regulatory T cells negatively affect IL-2 production of effector T cells through CD39/adenosine pathway in HIV infectionMohammad-Ali Jenabian, Nabila Seddiki, Ahmad Yatim, et al.
AIDS and Behavior|November 7, 2022
Disentangling Medicinal and Recreational cannabis Use Among People Living with HIV: An Ecological Momentary Assessment StudyJeffrey D Wardell, Sergio Rueda, Nicolle Fox, et al.
Pageof 11